Publicacions
-
Munier FL, Beck-Popovic M, Chantada G, Cobrinik D, Kivelä TT, Lohmann D, Maeder P, Moll AC, Carcaboso AM, Moulin A, Schaiquevich P, Bergin C, Dyson PJ, Houghton S, Puccinelli F, Vial Y, Gaillard MC and Stathopoulos C.
Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"
PROGRESS IN RETINAL AND EYE RESEARCH . 73: 100764-100764. Nº de cites: 131
-
Aschero MR, Torbidoni A, Sampor C, Laurent V, Zugbi S, Winter U, Lubieniecki F, Alonso D, Schaiquevich P and Chantada G.
Minimally disseminated disease and outcome in overt orbital retinoblastoma
PEDIATRIC BLOOD & CANCER . 66(6): . Nº de cites: 6
-
Pascual-Pastó G, Bazan-Peregrino M, Gene-Olaciregui N, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, Weber K, Correa MG, Paco-Mercader S, Vilà-Ubach M, Cuadrado-Vilanova M, Castillo H, Botteri G, García-Gerique L, Moreno-Gilabert H, Gimenez-Alejandre M, Alonso-Lopez P, Farrera-Sal M, Torres-Manjon S, Ramos-Lozano D, Moreno R, Aerts I, Doz F, Cassoux N, Chapeaublanc E, Torrebadell-Burriel M, Roldan-Molina M, König A, Suñol M, Claverol J, Lavarino C, de Torres C, Fu L, Radvanyi F, Munier FL, Català-Mora J, Mora J, Alemany R, Cascallo M, Chantada G and Carcaboso AM.
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
SCIENCE TRANSLATIONAL MEDICINE . 11(476): 9321. Nº de cites: 77
-
Torbidoni AV, Sampor C, Laurent VE, Aschero MR, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I and Chantada G.
Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma
BRITISH JOURNAL OF OPHTHALMOLOGY . 102(11): 1597-1601. Nº de cites: 5
-
Pérez V, Sampor C, Rey G, Parareda A, Kopp K, Dabezies AP, Dufort G, Zelter M, López JP, Urbieta M, Alcalde-Ruiz E, Català-Mora J, Suñol M, Ossandon D, Fandiño AC, Croxatto JO, de Dávila MTG, Reaman G, Ravindranath Y and Chantada G.
Treatment of Nonmetastatic Unilateral Retinoblastoma in Children
JAMA OPHTHALMOLOGY . 136(7): 747-752. Nº de cites: 29
-
Howard SC, Davidson A, Luna-Fineman S, Israels T, Chantada G, Lam CG, Hunger SP, Bailey S, Ribeiro RC, Arora RS, Pedrosa F, Harif M and Metzger ML.
A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP).
PEDIATRIC BLOOD & CANCER . 64 Suppl 5: . Nº de cites: 56
-
Pascual-Pastó G, Gene-Olaciregui N, Opezzo JAW, Castillo-Ecija H, Cuadrado-Vilanova M, Paco-Mercader S, Rivero EM, Vilà-Ubach M, Restrepo-Perdomo CA, Torrebadell-Burriel M, Suñol M, Schaquevich P, Mora J, Bramuglia GF, Chantada G and Carcaboso AM.
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier
JOURNAL OF CONTROLLED RELEASE . 264: 34-44. Nº de cites: 13
-
Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
CANCER LETTERS . 380(1): 10-19. Nº de cites: 26
-
Winter U, Mena HA, Negrotto S, Arana E, Pascual-Pastó G, Laurent V, Suñol M, Chantada G, Carcaboso AM and Schaiquevich P.
Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells
PLoS One . 11(7): . Nº de cites: 21
-
Rosé A, André N, Rozados VR, Mainetti LE, Márquez MM, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Mora J, García WG, Epelman S, Alasino C, Alonso D, Chantada G and Scharovsky OG.
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.
ecancermedicalscience . 10: 672-672. Nº de cites: 10